Literature DB >> 18201294

Adrenocorticotropic hormone and cortisol plasma levels directly correlate with childhood neglect and depression measures in addicted patients.

Gilberto Gerra1, Claudio Leonardi, Elena Cortese, Amir Zaimovic, Grazia Dell'Agnello, Matteo Manfredini, Lorenzo Somaini, Francesca Petracca, Vincenzo Caretti, Cristina Baroni, Claudio Donnini.   

Abstract

Hypothalamic-pituitary-adrenal (HPA) axis dysfunction has been reported to be involved in vulnerability to alcohol and drug dependence in humans, possibly underlying both addictive behaviour and depression susceptibility. The aim of the present study was to investigate the possible interactions between childhood adverse experiences, depressive symptoms and HPA axis function in addicted patients, in comparison with healthy control. Eighty-two abstinent heroin or cocaine dependent patients and 44 normal controls, matched for age and sex, completed the symptoms Check List-90 (SCL-90), measuring depressive symptoms, and the Childhood Experience of Care and Abuse Questionnaire. Blood samples were collected to determine adrenocorticotropic hormone (ACTH) and cortisol basal plasma levels at 8:00 and 8:30 a.m. Addicted individuals showed significantly higher neglect and depression scores and ACTH-cortisol plasma levels respect to control subjects. Depression scores at SCL-90 in addicted patients positively correlated with plasma ACTH and cortisol values. In turn, plasma ACTH levels were directly associated with childhood neglect measures, reaching statistical significance with 'mother-neglect' scores. Plasma cortisol levels were related to 'father antipathy' among cocaine addicts. These findings suggest the possibility that childhood experience of neglect and poor parent-child attachment may have a persistent effect on HPA axis function as an adult, partially contributing, together with genetic factors and other environmental conditions, to both depressive traits and substance abuse neurobiological vulnerability.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18201294     DOI: 10.1111/j.1369-1600.2007.00086.x

Source DB:  PubMed          Journal:  Addict Biol        ISSN: 1355-6215            Impact factor:   4.280


  8 in total

Review 1.  Substance use modulates stress reactivity: Behavioral and physiological outcomes.

Authors:  Anne Q Fosnocht; Lisa A Briand
Journal:  Physiol Behav       Date:  2016-02-19

2.  Hypertension in adult survivors of child abuse: observations from the Nurses' Health Study II.

Authors:  E H Riley; R J Wright; H J Jun; E N Hibert; J W Rich-Edwards
Journal:  J Epidemiol Community Health       Date:  2010-05       Impact factor: 3.710

Review 3.  The Neuroscience of Drug Reward and Addiction.

Authors:  Nora D Volkow; Michael Michaelides; Ruben Baler
Journal:  Physiol Rev       Date:  2019-10-01       Impact factor: 37.312

Review 4.  Social vulnerabilities for substance use: Stressors, socially toxic environments, and discrimination and racism.

Authors:  Hortensia Amaro; Mariana Sanchez; Tara Bautista; Robynn Cox
Journal:  Neuropharmacology       Date:  2021-03-11       Impact factor: 5.250

5.  BDNF and Cortisol in the Diagnosis of Cocaine-Induced Depression.

Authors:  Francina Fonseca; Joan Ignasi Mestre-Pinto; Rocío Rodríguez-Minguela; Esther Papaseit; Clara Pérez-Mañá; Klaus Langohr; Margherita Barbuti; Magí Farré; Marta Torrens
Journal:  Front Psychiatry       Date:  2022-03-15       Impact factor: 4.157

6.  Chronic ketamine abuse is associated with orexin-A reduction and ACTH elevation.

Authors:  Ming-Chyi Huang; Chun-Hsin Chen; Lian-Yu Chen; Hu-Ming Chang; Chih-Ken Chen; Shih-Ku Lin; Ke Xu
Journal:  Psychopharmacology (Berl)       Date:  2019-08-03       Impact factor: 4.530

7.  Childhood trauma in bipolar disorder.

Authors:  Stuart Watson; Peter Gallagher; Dominic Dougall; Richard Porter; Joanna Moncrieff; I Nicol Ferrier; Allan H Young
Journal:  Aust N Z J Psychiatry       Date:  2013-12-16       Impact factor: 5.744

8.  Epigenetic Risk Factors in PTSD and Depression.

Authors:  Florian Joachim Raabe; Dietmar Spengler
Journal:  Front Psychiatry       Date:  2013-08-07       Impact factor: 4.157

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.